Discovery of xanthine oxidase inhibitors and/or α-glucosidase inhibitors by carboxyalkyl derivatization based on the flavonoid of apigenin.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2015-07-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2015.05.016PMID 26022844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives.

  2014cited by this paper
• Antioxidant Capacities of Flavones and Benefits in Oxidative-Stress Related Diseases.

  2014cited by this paper
• Synthesis and anti-hyperglycemic activity of hesperidin derivatives.

  2012cited by this paper
• Biopharmaceutics classification and intestinal absorption study of apigenin.

  2012cited by this paper
• Targeting Inflammatory Pathways by Flavonoids for Prevention and Treatment of Cancer

  2010cited by this paper
• Enhanced stability and intracellular accumulation of quercetin by protection of the chemically or metabolically susceptible hydroxyl groups with a pivaloxymethyl (POM) promoiety.

  2010cited by this paper
• Apigenin: A Promising Molecule for Cancer Prevention

  2010cited by this paper
• Antihyperglycaemic and protective effects of flavonoids on streptozotocin–induced diabetic rats

  2010cited by this paper
• Screening and structural characterization of α-glucosidase inhibitors from hawthorn leaf flavonoids extract by ultrafiltration LC-DAD-MSn and SORI-CID FTICR MS

  2009cited by this paper
• Apigenin and cancer chemoprevention: progress, potential and promise (review).

  2007cited by this paper
• Hypouricemic action of selected flavonoids in mice: structure-activity relationships.

  2007cited by this paper
• Intestinal and hepatic glucuronidation of flavonoids.

  2007cited by this paper
• Planar catechin analogues with alkyl side chains: a potent antioxidant and an alpha-glucosidase inhibitor.

  2006cited by this paper
• Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability

  2006cited by this paper
• Xanthine oxidase inhibitors from the flowers of Chrysanthemum sinense.

  2006cited by this paper
• Hypouricemic effects of acacetin and 4,5-o-dicaffeoylquinic acid methyl ester on serum uric acid levels in potassium oxonate-pretreated rats.

  2005cited by this paper
• Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic Acid]: A Potent Xanthine Oxidoreductase Inhibitor with Hepatic Excretion

  2004cited by this paper
• An Extremely Potent Inhibitor of Xanthine Oxidoreductase

  2003cited by this paper
• Molecular modeling of flavonoids that inhibits xanthine oxidase.

  2002cited by this paper
• Synthesis and hypoglycemic effect of chrysin derivatives.

  1999cited by this paper
• Inhibitors of xanthine oxidase from the flowers and buds of Daphne genkwa.

  1983cited by this paper

• Xanthine oxidase inhibitors for gout: Applications and novel drug development.

  2026cites this paper
• From Ethnopharmacology to Active Compound: Effects of Traditional Plant Extracts on Varicose Vein-Related Enzymes and Isolation of Active Flavonoids from Helichrysum plicatum DC. subsp. plicatum

  2025cites this paper
• Investigation of binding mechanism for newly synthesized apigenin derivatives with xanthine oxidase: spectroscopic and computational approach

  2025cites this paper
• Flavonoids as dual-target inhibitors against α-glucosidase and α-amylase: a systematic review of in vitro studies

  2024cites this paper
• Organic acid-assisted heat treatment enhances the xanthine oxidase inhibitory activity of Flos Sophorae Immaturus tea.

  2024cites this paper
• The synthesis and bioactivity of Apigenin derivatives.

  2024cites this paper
• A comprehensive review of apigenin a dietary flavonoid: biological sources, nutraceutical prospects, chemistry and pharmacological insights and health benefits

  2024cites this paper
• A Study of the Interaction between Xanthine Oxidase and Its Inhibitors from Chrysanthemum morifolium Using Computational Simulation and Multispectroscopic Methods

  2023cites this paper
• A pharmaceutical cocrystal of apigenin with piperazine: preparation, structural characterization, and dissolution performance

  2023cites this paper
• Recent Advances in Xanthine Oxidase Inhibitors.

  2023cites this paper
• Discovery of Natural Multitarget Xanthine Oxidase Inhibitors for Therapeutic Hyperuricemia Using Virtual Screening, Network Pharmacology and in vitro Experimental Verification

  2023cites this paper
• Mechanism of flavonoids inhibiting xanthine oxidase and alleviating hyperuricemia from structure–activity relationship and animal experiments: A review

  2023cites this paper
• Identification of coniferyl ferulate as the bioactive compound behind the xanthine oxidase inhibitory activity of Chuanxiong Rhizome

  2023cites this paper
• Research progress on antidiabetic activity of apigenin derivatives

  2022cites this paper
• Recent Advances in Alleviating Hyperuricemia Through Dietary Sources: Bioactive Ingredients and Structure–activity Relationships

  2022cites this paper
• Study on the interaction mechanism between luteoloside and xanthine oxidase by multi‐spectroscopic and molecular docking methods

  2022cites this paper
• Fast dereplication of xanthine oxidase-inhibiting compounds in alfalfa using comparative metabolomics.

  2021cites this paper
• Gene set enrichment analysis, network pharmacology and in silico docking approach to understand the molecular mechanism of traditional medicines for the treatment of diabetes mellitus

  2020cites this paper
• Effects of Hydroxyl Group on the Interaction of Carboxylated Flavonoid Derivatives with S. Cerevisiae α-Glucosidase

  2020cites this paper
• From Xanthine Oxidase Inhibition to In Vivo Hypouricemic Effect: An Integrated Overview of In Vitro and In Vivo Studies with Focus on Natural Molecules and Analogues

  2020cites this paper
• Synthesis and cytotoxic activity of 7,4’-O-modified genistein amino acid derivatives

  2019cites this paper
• Extensive Structure Modification on Luteolin-Cinnamic Acid Conjugates Leading to BACE1 Inhibitors with Optimal Pharmacological Properties

  2019cites this paper
• Spectrum-effect relationship between HPLC fingerprints and bioactive components of Radix Hedysari on increasing the peak bone mass of rat

  2018cites this paper
• Apigenin isolated from A. americana encodes Human and Aspergillus oryzae S2 α-amylase inhibitions: credible approach for antifungal and antidiabetic therapies

  2018cites this paper
• Molecular dynamics simulation integrating the inhibition kinetics of hydroxysafflor yellow A on α-glucosidase

  2018cites this paper
• Xanthine oxidase inhibitors from Archidendron clypearia (Jack.) I.C. Nielsen: Results from systematic screening of Vietnamese medicinal plants.

  2017cites this paper
• An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015)

  2017cites this paper
• Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.

  2017cites this paper
• Recent Advances in Synthetic α‐Glucosidase Inhibitors

  2017cites this paper
• Probing the influence of carboxyalkyl groups on the molecular flexibility and the charge density of apigenin derivatives

  2017cites this paper
• Comparison of the molecular interactions of 7′-carboxyalkyl apigenin derivatives with S. cerevisiae α-glucosidase

  2017cites this paper
• Mushroom (Agaricus bisporus) polyphenoloxidase inhibited by apigenin: Multi-spectroscopic analyses and computational docking simulation.

  2016cites this paper
• Quantification and bio-assay of α-glucosidase inhibitors from the roots of Glycyrrhiza uralensis Fisch.

  2016cites this paper